Concepts (162)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Receptors, Adrenergic, beta-2 | 14 | 2017 | 90 | 2.260 |
Why?
|
Endocytosis | 7 | 2010 | 132 | 0.910 |
Why?
|
Epinephrine | 6 | 2017 | 181 | 0.580 |
Why?
|
Nadolol | 5 | 2017 | 29 | 0.550 |
Why?
|
Asthma | 9 | 2017 | 812 | 0.510 |
Why?
|
Interleukin-13 | 2 | 2017 | 101 | 0.500 |
Why?
|
Bronchi | 2 | 2017 | 108 | 0.490 |
Why?
|
Mucin 5AC | 1 | 2015 | 25 | 0.480 |
Why?
|
Epithelial Cells | 3 | 2017 | 935 | 0.460 |
Why?
|
Adrenergic beta-Antagonists | 6 | 2017 | 252 | 0.450 |
Why?
|
Adrenergic beta-2 Receptor Antagonists | 2 | 2017 | 13 | 0.390 |
Why?
|
G-Protein-Coupled Receptor Kinases | 1 | 2010 | 5 | 0.340 |
Why?
|
Mutant Proteins | 1 | 2010 | 118 | 0.320 |
Why?
|
Leucine | 1 | 2010 | 312 | 0.300 |
Why?
|
1-Phosphatidylinositol 4-Kinase | 1 | 2007 | 10 | 0.280 |
Why?
|
Chromones | 1 | 2007 | 26 | 0.280 |
Why?
|
Morpholines | 1 | 2007 | 64 | 0.270 |
Why?
|
Propanolamines | 4 | 2017 | 33 | 0.260 |
Why?
|
Adrenergic beta-2 Receptor Agonists | 3 | 2016 | 65 | 0.250 |
Why?
|
Phosphorylation | 8 | 2017 | 1701 | 0.210 |
Why?
|
Cyclic AMP-Dependent Protein Kinases | 4 | 2015 | 170 | 0.200 |
Why?
|
Receptors, Cell Surface | 2 | 2002 | 497 | 0.200 |
Why?
|
Cyclic AMP | 2 | 2015 | 262 | 0.200 |
Why?
|
Adrenergic beta-Agonists | 4 | 2007 | 94 | 0.200 |
Why?
|
Cell Line | 7 | 2010 | 2836 | 0.180 |
Why?
|
GTP-Binding Proteins | 1 | 2002 | 188 | 0.180 |
Why?
|
Signal Transduction | 5 | 2017 | 4897 | 0.180 |
Why?
|
Carbazoles | 2 | 2017 | 35 | 0.170 |
Why?
|
Protein Transport | 4 | 2010 | 386 | 0.170 |
Why?
|
Eosinophils | 2 | 2017 | 127 | 0.160 |
Why?
|
Kinetics | 5 | 2010 | 1355 | 0.150 |
Why?
|
Serine | 3 | 2010 | 184 | 0.150 |
Why?
|
Mutation | 4 | 2010 | 6290 | 0.140 |
Why?
|
Phenylethanolamine N-Methyltransferase | 1 | 2016 | 2 | 0.130 |
Why?
|
Phosphodiesterase 4 Inhibitors | 1 | 2016 | 7 | 0.130 |
Why?
|
rab GTP-Binding Proteins | 2 | 2007 | 51 | 0.110 |
Why?
|
Lung | 3 | 2017 | 1557 | 0.110 |
Why?
|
Cattle | 1 | 2015 | 587 | 0.110 |
Why?
|
Ovalbumin | 5 | 2017 | 321 | 0.110 |
Why?
|
Ligands | 3 | 2011 | 572 | 0.110 |
Why?
|
MAP Kinase Signaling System | 1 | 2015 | 324 | 0.110 |
Why?
|
Mucins | 2 | 2015 | 77 | 0.100 |
Why?
|
Inflammation | 4 | 2017 | 1590 | 0.100 |
Why?
|
Animals | 13 | 2017 | 36377 | 0.090 |
Why?
|
Transfection | 2 | 2011 | 1089 | 0.090 |
Why?
|
Mice, Inbred BALB C | 5 | 2017 | 1079 | 0.080 |
Why?
|
Immunoblotting | 1 | 2011 | 317 | 0.080 |
Why?
|
Down-Regulation | 2 | 2010 | 717 | 0.080 |
Why?
|
Amino Acid Motifs | 1 | 2010 | 204 | 0.080 |
Why?
|
G-Protein-Coupled Receptor Kinase 1 | 2 | 2006 | 3 | 0.080 |
Why?
|
Cell Culture Techniques | 1 | 2011 | 292 | 0.080 |
Why?
|
Arrestins | 2 | 2006 | 30 | 0.080 |
Why?
|
beta-Adrenergic Receptor Kinases | 2 | 2006 | 26 | 0.080 |
Why?
|
Adenylyl Cyclases | 3 | 2006 | 89 | 0.080 |
Why?
|
Green Fluorescent Proteins | 2 | 2007 | 401 | 0.080 |
Why?
|
Myosin Type V | 1 | 2008 | 9 | 0.080 |
Why?
|
Disease Models, Animal | 4 | 2017 | 4778 | 0.070 |
Why?
|
Myosin Heavy Chains | 1 | 2008 | 78 | 0.070 |
Why?
|
HEK293 Cells | 1 | 2011 | 813 | 0.070 |
Why?
|
Metoprolol | 1 | 2007 | 22 | 0.070 |
Why?
|
Transferrin | 1 | 2007 | 50 | 0.070 |
Why?
|
Cytoskeleton | 1 | 2008 | 175 | 0.070 |
Why?
|
Humans | 15 | 2017 | 133390 | 0.070 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2011 | 1733 | 0.070 |
Why?
|
Endosomes | 2 | 2003 | 68 | 0.060 |
Why?
|
Albuterol | 1 | 2006 | 53 | 0.060 |
Why?
|
Dynamin I | 1 | 2006 | 3 | 0.060 |
Why?
|
G-Protein-Coupled Receptor Kinase 3 | 1 | 2006 | 11 | 0.060 |
Why?
|
G-Protein-Coupled Receptor Kinase 2 | 1 | 2006 | 16 | 0.060 |
Why?
|
Actins | 1 | 2008 | 350 | 0.060 |
Why?
|
Phenotype | 4 | 2017 | 4551 | 0.060 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2007 | 589 | 0.060 |
Why?
|
Receptors, Adrenergic, beta | 1 | 2004 | 65 | 0.050 |
Why?
|
Receptors, Somatostatin | 1 | 2003 | 56 | 0.050 |
Why?
|
Neuroendocrine Tumors | 1 | 2003 | 55 | 0.050 |
Why?
|
Alprenolol | 2 | 2015 | 10 | 0.050 |
Why?
|
Bronchoalveolar Lavage Fluid | 2 | 2015 | 157 | 0.040 |
Why?
|
Microscopy, Fluorescence | 1 | 2002 | 336 | 0.040 |
Why?
|
Cells, Cultured | 1 | 2006 | 3168 | 0.040 |
Why?
|
Mice | 6 | 2017 | 18910 | 0.040 |
Why?
|
Methacholine Chloride | 2 | 2009 | 22 | 0.040 |
Why?
|
Mice, Inbred C57BL | 3 | 2017 | 4822 | 0.040 |
Why?
|
Pyroglyphidae | 1 | 2017 | 9 | 0.040 |
Why?
|
Mice, Knockout | 2 | 2016 | 3981 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 1 | 2017 | 97 | 0.030 |
Why?
|
Respiratory Hypersensitivity | 1 | 2017 | 54 | 0.030 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2017 | 115 | 0.030 |
Why?
|
Metaplasia | 1 | 2017 | 218 | 0.030 |
Why?
|
Mucus | 1 | 2016 | 39 | 0.030 |
Why?
|
Formoterol Fumarate | 1 | 2016 | 34 | 0.030 |
Why?
|
Bronchial Hyperreactivity | 1 | 2016 | 38 | 0.030 |
Why?
|
Fluorescent Antibody Technique | 2 | 2007 | 433 | 0.030 |
Why?
|
Isoproterenol | 2 | 2006 | 109 | 0.030 |
Why?
|
Cyclopropanes | 1 | 2016 | 70 | 0.030 |
Why?
|
Aminopyridines | 1 | 2016 | 60 | 0.030 |
Why?
|
Benzamides | 1 | 2016 | 125 | 0.030 |
Why?
|
Cell Count | 1 | 2015 | 240 | 0.030 |
Why?
|
Propranolol | 1 | 2015 | 130 | 0.030 |
Why?
|
Blotting, Western | 2 | 2007 | 1134 | 0.030 |
Why?
|
Cell Membrane | 2 | 2006 | 486 | 0.030 |
Why?
|
Pneumonia | 1 | 2017 | 342 | 0.030 |
Why?
|
Allergens | 1 | 2015 | 278 | 0.030 |
Why?
|
Drug Therapy, Combination | 1 | 2016 | 1193 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2017 | 2526 | 0.020 |
Why?
|
Models, Biological | 1 | 2015 | 1532 | 0.020 |
Why?
|
Bronchoconstrictor Agents | 1 | 2009 | 11 | 0.020 |
Why?
|
Thiazolidines | 1 | 2008 | 2 | 0.020 |
Why?
|
Cytochalasin D | 1 | 2008 | 11 | 0.020 |
Why?
|
Bridged Bicyclo Compounds, Heterocyclic | 1 | 2008 | 42 | 0.020 |
Why?
|
Injections, Intraperitoneal | 1 | 2007 | 75 | 0.020 |
Why?
|
Specific Pathogen-Free Organisms | 1 | 2007 | 61 | 0.020 |
Why?
|
Infusion Pumps | 1 | 2007 | 34 | 0.020 |
Why?
|
Bronchial Provocation Tests | 1 | 2007 | 15 | 0.020 |
Why?
|
Airway Resistance | 1 | 2007 | 37 | 0.020 |
Why?
|
Salmeterol Xinafoate | 1 | 2006 | 14 | 0.020 |
Why?
|
Phosphoserine | 1 | 2006 | 42 | 0.020 |
Why?
|
Male | 4 | 2017 | 65685 | 0.020 |
Why?
|
Pindolol | 1 | 2006 | 8 | 0.020 |
Why?
|
beta-Arrestin 1 | 1 | 2006 | 5 | 0.020 |
Why?
|
beta-Arrestin 2 | 1 | 2006 | 12 | 0.020 |
Why?
|
beta-Arrestins | 1 | 2006 | 34 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2007 | 755 | 0.020 |
Why?
|
Aspartic Acid | 1 | 2006 | 84 | 0.020 |
Why?
|
Administration, Oral | 1 | 2007 | 726 | 0.020 |
Why?
|
Alanine | 1 | 2006 | 189 | 0.010 |
Why?
|
DNA, Complementary | 1 | 2006 | 472 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2006 | 866 | 0.010 |
Why?
|
G-Protein-Coupled Receptor Kinase 5 | 1 | 2003 | 5 | 0.010 |
Why?
|
Somatostatinoma | 1 | 2003 | 1 | 0.010 |
Why?
|
Ileal Neoplasms | 1 | 2003 | 8 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2006 | 781 | 0.010 |
Why?
|
Subcellular Fractions | 1 | 2003 | 99 | 0.010 |
Why?
|
CHO Cells | 1 | 2003 | 166 | 0.010 |
Why?
|
Pheochromocytoma | 1 | 2003 | 39 | 0.010 |
Why?
|
Carcinoid Tumor | 1 | 2003 | 27 | 0.010 |
Why?
|
Cricetinae | 1 | 2003 | 398 | 0.010 |
Why?
|
Tissue Distribution | 1 | 2003 | 400 | 0.010 |
Why?
|
Biological Transport | 1 | 2003 | 369 | 0.010 |
Why?
|
Adrenal Gland Neoplasms | 1 | 2003 | 80 | 0.010 |
Why?
|
Binding Sites | 1 | 2006 | 1370 | 0.010 |
Why?
|
rab4 GTP-Binding Proteins | 1 | 2002 | 1 | 0.010 |
Why?
|
rab1 GTP-Binding Proteins | 1 | 2002 | 4 | 0.010 |
Why?
|
rab5 GTP-Binding Proteins | 1 | 2002 | 13 | 0.010 |
Why?
|
Gene Expression | 1 | 2006 | 1614 | 0.010 |
Why?
|
Diethylstilbestrol | 1 | 1980 | 140 | 0.010 |
Why?
|
Oviducts | 1 | 1980 | 338 | 0.010 |
Why?
|
Lysosomes | 1 | 2002 | 262 | 0.010 |
Why?
|
Genes | 1 | 1980 | 450 | 0.010 |
Why?
|
Protein Binding | 1 | 2003 | 1832 | 0.010 |
Why?
|
Kidney | 1 | 2006 | 1416 | 0.010 |
Why?
|
Pancreatic Neoplasms | 1 | 2003 | 732 | 0.010 |
Why?
|
Female | 3 | 2015 | 71455 | 0.010 |
Why?
|
Time Factors | 1 | 2006 | 6569 | 0.010 |
Why?
|
DNA Restriction Enzymes | 1 | 1980 | 122 | 0.000 |
Why?
|
Poly A | 1 | 1980 | 60 | 0.000 |
Why?
|
Microscopy, Electron | 1 | 1980 | 366 | 0.000 |
Why?
|
Chickens | 1 | 1980 | 640 | 0.000 |
Why?
|
Nucleic Acid Hybridization | 1 | 1980 | 397 | 0.000 |
Why?
|
Bacteriophages | 1 | 1980 | 85 | 0.000 |
Why?
|
Recombination, Genetic | 1 | 1980 | 452 | 0.000 |
Why?
|
Transcription, Genetic | 1 | 1980 | 1755 | 0.000 |
Why?
|
RNA, Messenger | 1 | 1980 | 2899 | 0.000 |
Why?
|